AMONETA DIAGNOSTICS
Early diagnosis of Alzheimer's Disease (AD) with a single drop of blood.
France
5 employees
Equity Crowdfunding
Biotechnology, Health Care
General Information
France
BounceWatch is an independent company data service, not affiliated with AMONETA DIAGNOSTICS. To contact AMONETA DIAGNOSTICS, visit amoneta-diagnostics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does AMONETA DIAGNOSTICS compare?
A PDF of AMONETA DIAGNOSTICS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting AMONETA DIAGNOSTICS soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is AMONETA DIAGNOSTICS on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
France Market
Biotechnology
About AMONETA DIAGNOSTICS
Business keywords: neurology, Alzheimer's Disease, diagnostics, biomarkers, blood test, innovation
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Equity Crowdfunding | Undisclosed | 1 |
|
08 Nov 2018 |
AMONETA DIAGNOSTICS Alternatives & Competitors
View All Alternatives
Setting new standards in Alzheimer's Diagnostics
Detect Alzheimer's earlier, when it could be prevented
Innovative Solutions for Cancer Diagnostics
FAQ About AMONETA DIAGNOSTICS
Source: BounceWatch company record for AMONETA DIAGNOSTICS, https://bouncewatch.com/company/amoneta-diagnostics, updated 26 December 2024. When citing, please name BounceWatch and link this page.
